⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. (SPRY) Shareholders of Class Action Lawsuit and October 5, 2026 Deadline
accessnewswire.com
SPRY
Kaplan Fox Alerts Investors of ARS Pharmaceuticals Inc. (SPRY) to a Pending Securities Class Action - Deadline is October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
SPRY
Securities Fraud Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Reminds Investors of October 5, 2026
accessnewswire.com
SPRY
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
globenewswire.com
SPRY
Faruqi & Faruqi, LLP Urges ARS Pharmaceuticals (NASDAQ: SPRY) Investors to Seek Counsel Before the October 5, 2026 Lead Plaintiff Deadline in the Securities Class Action
accessnewswire.com
SPRY
Investors Urged to Contact Levi & Korsinsky for Information Before October 5, 2026 – ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Pomerantz LLP Alerts Shareholders to Investor Suit Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Securities Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) – Levi & Korsinsky Represents Shareholders
accessnewswire.com
SPRY
Class Action Lawsuit Filed: ARS Pharmaceuticals, Inc. (SPRY) – Join by October 5, 2026 – Contact Levi & Korsinsky
accessnewswire.com
SPRY